Join leading national experts as they discuss the evolving landscape of chronic kidney disease management in patients with type 2 diabetes. This panel explores the 2026 vision for optimizing the prevention continuum, with a strong focus on integrated cardio-renal-metabolic care. The discussion highlights early risk identification, timely therapeutic interventions, and strategies to slow disease progression while improving long-term outcomes.

Beat the Drop for CKD

President – HFAI, Senior Consultatnt & Interventional Cardiologist, Apollo Hospital, Chennai

A comprehensive two-day symposium on Hypertrophic Cardiomyopathy (HCM), bringing together leading experts to explore the evolving landscape of HCM diagnosis, risk stratification, and evidence-based management. Through expert-led sessions, live echocardiography cases, interactive clinical discussions, and engaging debates, the symposium will address key challenges in identifying HCM, distinguishing mimics, assessing sudden cardiac death risk, optimizing medical therapy, and navigating advanced treatment options, including myosin inhibitors and septal reduction therapies. Designed to bridge clinical evidence with real-world practice, the program aims to equip cardiologists with practical insights and greater confidence in managing patients across the HCM spectrum.

Dr. Abraham Oomman

2

678

13.4k

4.7

Upcoming Sessions

Sessions Taken

924

4.7